Market Cap 144.35M
Revenue (ttm) 18.00M
Net Income (ttm) -47.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -265.17%
Debt to Equity Ratio 0.10
Volume 566,400
Avg Vol 352,216
Day's Range N/A - N/A
Shares Out 105.36M
Stochastic %K 4%
Beta 0.21
Analysts Strong Sell
Price Target $8.88

Company Profile

ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Re...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 88 166 7000
Address:
Zernikedreef 9, Leiden, Netherlands
ehpats
ehpats Mar. 27 at 7:48 PM
$PRQR I was starting feel good about that slow grind up to $1.80 but that got wiped out in few days.
2 · Reply
johnnygogogo
johnnygogogo Mar. 27 at 7:39 PM
$PRQR enterprise value of only $40M~ is fucking nuts
0 · Reply
justfacts1
justfacts1 Mar. 27 at 4:53 PM
$PRQR down on heavy volume?!
1 · Reply
FutureInvesting777
FutureInvesting777 Mar. 27 at 3:52 PM
$PRQR nothing new;l! bring it down on no volume.
0 · Reply
tixenalp
tixenalp Mar. 27 at 9:32 AM
$PRQR still on watch because this price still doesn’t make sense.
1 · Reply
ACH50
ACH50 Mar. 26 at 3:19 PM
0 · Reply
LeftyT
LeftyT Mar. 26 at 3:17 PM
$PRQR Added 10% to my position this morning at 1.515 as I initiate my accumulation phase for this stock.
1 · Reply
LeftyT
LeftyT Mar. 26 at 2:58 PM
$PRQR just made the "top 10" list for stocks under $5 can can triple up over the next 12 months, so some people are starting to pay attention to this early stage opportunity. If they keep posting great safety data and start to show some efficacy data this stock will really take off in 2026.
0 · Reply
biochirp
biochirp Mar. 26 at 2:04 PM
$PRQR it was an siRNA not a RNA editor, so no read through for PRQR
1 · Reply
Geert07
Geert07 Mar. 26 at 1:19 PM
$PRQR WVE gets a beating today because of disappointing phase 1 data.
0 · Reply
Latest News on PRQR
ProQR Announces Year End 2025 Operating and Financial Results

Mar 12, 2026, 7:00 AM EDT - 17 days ago

ProQR Announces Year End 2025 Operating and Financial Results


ProQR Announces Planned Changes to Board Composition

Feb 9, 2026, 8:00 AM EST - 6 weeks ago

ProQR Announces Planned Changes to Board Composition


ProQR Announces Upcoming Presentation at RNA Editing Summit

Jul 28, 2025, 8:00 AM EDT - 8 months ago

ProQR Announces Upcoming Presentation at RNA Editing Summit


ProQR Announces Year End 2024 Operating and Financial Results

Mar 13, 2025, 7:00 AM EDT - 1 year ago

ProQR Announces Year End 2024 Operating and Financial Results


ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

Dec 10, 2024, 8:00 AM EST - 1 year ago

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist


ProQR Announces Year End 2023 Operating and Financial Results

Mar 13, 2024, 7:00 AM EDT - 2 years ago

ProQR Announces Year End 2023 Operating and Financial Results


ProQR: Too Many Failures For Its RNA Technology

Jul 9, 2023, 6:53 AM EDT - 2 years ago

ProQR: Too Many Failures For Its RNA Technology


ProQR Announces Upcoming Investor Conferences in April and May

Apr 20, 2023, 8:00 AM EDT - 3 years ago

ProQR Announces Upcoming Investor Conferences in April and May


ProQR's stock jumps on expanded RNA deal with Lilly

Dec 22, 2022, 9:12 AM EST - 3 years ago

ProQR's stock jumps on expanded RNA deal with Lilly

LLY


ehpats
ehpats Mar. 27 at 7:48 PM
$PRQR I was starting feel good about that slow grind up to $1.80 but that got wiped out in few days.
2 · Reply
johnnygogogo
johnnygogogo Mar. 27 at 7:39 PM
$PRQR enterprise value of only $40M~ is fucking nuts
0 · Reply
justfacts1
justfacts1 Mar. 27 at 4:53 PM
$PRQR down on heavy volume?!
1 · Reply
FutureInvesting777
FutureInvesting777 Mar. 27 at 3:52 PM
$PRQR nothing new;l! bring it down on no volume.
0 · Reply
tixenalp
tixenalp Mar. 27 at 9:32 AM
$PRQR still on watch because this price still doesn’t make sense.
1 · Reply
ACH50
ACH50 Mar. 26 at 3:19 PM
0 · Reply
LeftyT
LeftyT Mar. 26 at 3:17 PM
$PRQR Added 10% to my position this morning at 1.515 as I initiate my accumulation phase for this stock.
1 · Reply
LeftyT
LeftyT Mar. 26 at 2:58 PM
$PRQR just made the "top 10" list for stocks under $5 can can triple up over the next 12 months, so some people are starting to pay attention to this early stage opportunity. If they keep posting great safety data and start to show some efficacy data this stock will really take off in 2026.
0 · Reply
biochirp
biochirp Mar. 26 at 2:04 PM
$PRQR it was an siRNA not a RNA editor, so no read through for PRQR
1 · Reply
Geert07
Geert07 Mar. 26 at 1:19 PM
$PRQR WVE gets a beating today because of disappointing phase 1 data.
0 · Reply
biochirp
biochirp Mar. 25 at 5:48 PM
$PRQR this better be good
1 · Reply
ehpats
ehpats Mar. 25 at 12:59 PM
$PRQR Prqr really needs to get some momentum going here. Maybe the investor analyst conference will fit the bill?
1 · Reply
Geert07
Geert07 Mar. 25 at 12:56 PM
$PRQR https://www.proqr.com/press-releases/proqr-to-host-virtual-investor-and-analyst-event-highlighting-pipeline-on-april-8-2026?utm_source=Newsletter&utm_medium=email&utm_campaign=PR_emailalerts
0 · Reply
tixenalp
tixenalp Mar. 25 at 8:07 AM
$PRQR buy on weakness, market value doesn’t reflect the intrinsic value.
0 · Reply
justfacts1
justfacts1 Mar. 24 at 9:05 PM
$PRQR 2 months to go.
0 · Reply
biochirp
biochirp Mar. 23 at 2:16 PM
$PRQR have to think management got greedy with $LLY
1 · Reply
dirkfrank
dirkfrank Mar. 20 at 9:32 AM
$PRQR poe poe. Weer terug naar 1.50$. Tweede kwartaal komt er aan en dan gaat HET gebeuren.
1 · Reply
LeftyT
LeftyT Mar. 18 at 8:31 PM
$PRQR Their CSO already has a ton of shares and now has stock options out the wazoo to top them off. Do you think he's motivated to make sure PRQR is successful? It sure looks that way to me!!
3 · Reply
buymoremakemore
buymoremakemore Mar. 12 at 11:31 PM
$PRQR Added another 10k shares. Anything under $2 a steal
1 · Reply
tixenalp
tixenalp Mar. 12 at 10:03 PM
$PRQR Waiting for more discount
0 · Reply
buymoremakemore
buymoremakemore Mar. 12 at 5:36 PM
$PRQR There is time to get into this. For cholestatic diseases they wont add people with PSC until later this year. The healthy volunteer data by end of H1 will still be good but data on people actually suffering from liver diseases, even if just phase 1 will be crucial. No timeline for when they'll initiate phase 1 for mash, and Rett syndrome not initiating until 2027. Either way, I like it
0 · Reply
notreload_ai
notreload_ai Mar. 12 at 12:50 PM
Oppenheimer starts $PRQR coverage with Outperform rating and $9 price target, citing RNA editing potential in liver diseases ahead of 2026 data. https://notreload.xyz/oppenheimer-initiates-prqr-outperform/
1 · Reply